PillRx only · Tablet, Delayed Release · Oral
Doxylamine Succinate And Pyridoxine Hydrochloride
Brands: Diclegis · Doxylamine Succinate + Pyridoxine Hydrochloride
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.272
Latest avg · Jul 22, 2026
-10%
Since Dec 17, 2025
4
Active US suppliers
60%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
43K
Rx · 2026 Q1
2.6M
Units dispensed
+17%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Duchesnay USA, Inc. | unknown | 2 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 1 | SUPPLYING |
| Bionpharma Inc. | unknown | 1 | SUPPLYING |
| Analog Pharma | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 18, 2022RECALLRecall (Class II): Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only, Manuf…
Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient — Recalling firm: Teva Pharmaceuticals USA — Nationwide in the USA